Skip to main content
Log in

Genetics of impulse control disorders in Parkinson’s disease

  • Neurology and Preclinical Neurological Studies - Review Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Impulse control disorders (ICD) have been recognised in Parkinson’s disease (PD) as adverse effects of dopamine replacement therapy, particularly with dopamine agonists. Although virtually all PD patients are treated with dopaminergic drugs, only a minority will develop hyperdopaminergic states, suggesting predisposing and/or protecting factors. The age at onset, the sex and the dose or type of dopaminergic drugs have been identified as clinical predictive factors. Recent genetic studies have investigated associations between ICD and polymorphisms of genes involved in the dopamine metabolism pathway (COMT, DAT), dopamine receptors (DRD1, DRD2, DRD3, DRD4), serotonin receptors and its transporter (HTR2A, 5HTT), and glutamate receptors (GRIN2B). Although validation in larger and independent cohorts is needed, the results from these studies give us some insights into the pathophysiology of hyperdopaminergic states and may be useful, at term, in personalising antiparkinsonian treatment in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Althaus M, Groen Y, Wijers AA, Mulder LJ, Minderaa RB, Kema IP, Dijck JD, Hartman CA, Hoekstra PJ (2009) Differential effects of 5-HTTLPR and DRD2/ANKK1 polymorphisms on electrocortical measures of error and feedback processing in children. Clin Neurophysiol 120(1):93–107. doi:10.1016/j.clinph.2008.10.012

    Article  PubMed  CAS  Google Scholar 

  • Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P (2011) Impulsivity and compulsivity in drug-naive patients with Parkinson’s disease. Mov Disord 26(3):464–468. doi:10.1002/mds.23501

    Article  PubMed  Google Scholar 

  • Ardouin C, Chereau I, Llorca PM, Lhommee E, Durif F, Pollak P, Krack P (2009) Assessment of hyper- and hypodopaminergic behaviors in Parkinson’s disease. Rev Neurol (Paris) 165(11):845–856. doi:10.1016/j.neurol.2009.06.003

    Article  CAS  Google Scholar 

  • Black DW, Moyer T (1998) Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49(11):1434–1439

    PubMed  CAS  Google Scholar 

  • Brewer JA, Potenza MN (2008) The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 75(1):63–75. doi:10.1016/j.bcp.2007.06.043

    Article  PubMed  CAS  Google Scholar 

  • Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Rosenthal RJ, Lesieur HR, Rugle LJ, MacMurray P (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2(1):44–56

    Article  PubMed  CAS  Google Scholar 

  • Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C, Koh P, Farwell K, Blake H, Dietz G, MacMurray JP, Lesieur HR, Rugle LJ, Rosenthal RJ (2001) The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 60(2):107–116. pii:cge600204

    Article  PubMed  CAS  Google Scholar 

  • Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56(4):993–998

    PubMed  CAS  Google Scholar 

  • Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP (2005) Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10(7):686–698. doi:10.1038/sj.mp.4001641

    Article  PubMed  CAS  Google Scholar 

  • da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V, Kennedy JL (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 23(4):421–433. doi:10.1007/s10899-007-9060-x

    Article  PubMed  Google Scholar 

  • Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH (1997) Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking. Mol Psychiatry 2(6):472–477

    Article  PubMed  CAS  Google Scholar 

  • Eisen SA, Lin N, Lyons MJ, Scherrer JF, Griffith K, True WR, Goldberg J, Tsuang MT (1998) Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 93(9):1375–1384

    Article  PubMed  CAS  Google Scholar 

  • Eisenegger C, Knoch D, Ebstein RP, Gianotti LR, Sandor PS, Fehr E (2010) Dopamine receptor D4 polymorphism predicts the effect of l-DOPA on gambling behavior. Biol Psychiatry 67(8):702–706. doi:10.1016/j.biopsych.2009.09.021

    Article  PubMed  CAS  Google Scholar 

  • Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33(8):1966–1979. doi:10.1038/sj.npp.1301565

    Article  PubMed  CAS  Google Scholar 

  • Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14(1):60–70. doi:10.1038/sj.mp.4002086

    Article  PubMed  CAS  Google Scholar 

  • Frank MJ, Seeberger LC, O’Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science 306(5703):1940–1943. doi:10.1126/science.1102941

    Article  PubMed  CAS  Google Scholar 

  • Gelernter J, Kranzler HR, Satel SL, Rao PA (1994) Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11(3):195–200. doi:10.1038/sj.npp.1380106

    Article  PubMed  CAS  Google Scholar 

  • Gorwood P, Le Strat Y, Ramoz N, Dubertret C, Moalic JM, Simonneau M (2012) Genetics of dopamine receptors and drug addiction. Hum Genet 131(6):803–822. doi:10.1007/s00439-012-1145-7

    Article  PubMed  CAS  Google Scholar 

  • Grice DE, Leckman JF, Pauls DL, Kurlan R, Kidd KK, Pakstis AJ, Chang FM, Buxbaum JD, Cohen DJ, Gelernter J (1996) Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am J Hum Genet 59(3):644–652

    PubMed  CAS  Google Scholar 

  • Guo G, Tong Y, Xie CW, Lange LA (2007) Dopamine transporter, gender, and number of sexual partners among young adults. Eur J Hum Genet 15(3):279–287. doi:10.1038/sj.ejhg.5201763

    Article  PubMed  CAS  Google Scholar 

  • Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66(6):2621–2624

    Article  PubMed  CAS  Google Scholar 

  • Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133–139. doi:10.1016/S0893-133X(99)00099-8

    Article  PubMed  CAS  Google Scholar 

  • Heitland I, Oosting RS, Baas JM, Massar SA, Kenemans JL, Bocker KB (2012) Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans. Cogn Affect Behav Neurosci. doi:10.3758/s13415-012-0108-8

    PubMed  Google Scholar 

  • Hersrud SL, Stoltenberg SF (2009) Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study. Eat Behav 10(2):131–133. doi:10.1016/j.eatbeh.2009.01.003

    Article  PubMed  Google Scholar 

  • Holden C (2001) ‘Behavioral’ addictions: do they exist? Science 294(5544):980–982. doi:10.1126/science.294.5544.980

    Article  PubMed  CAS  Google Scholar 

  • Ibanez A, Blanco C, Perez de Castro I, Fernandez-Piqueras J, Saiz-Ruiz J (2003) Genetics of pathological gambling. J Gambl Stud 19(1):11–22

    Article  PubMed  Google Scholar 

  • Juhasz G, Downey D, Hinvest N, Thomas E, Chase D, Toth ZG, Lloyd-Williams K, Mekli K, Platt H, Payton A, Bagdy G, Elliott R, Deakin JF, Anderson IM (2010) Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders. Neuropsychopharmacology 35(5):1109–1119. doi:10.1038/npp.2009.216

    Article  PubMed  CAS  Google Scholar 

  • Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162(8):1403–1413. doi:10.1176/appi.ajp.162.8.1403

    Article  PubMed  Google Scholar 

  • Karkowski LM, Prescott CA, Kendler KS (2000) Multivariate assessment of factors influencing illicit substance use in twins from female–female pairs. Am J Med Genet 96(5):665–670. doi:10.1002/1096-8628(20001009)96:5<665AID-AJMG13>3.0.CO;2-O

    Article  PubMed  CAS  Google Scholar 

  • Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, Kramer I, Zer-Zion M, Kletz I, Ebstein RP (1997) Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 2(3):251–254

    Article  PubMed  CAS  Google Scholar 

  • Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5(1):85–108. doi:10.1385/NMM:5:1:085

    Article  PubMed  CAS  Google Scholar 

  • Kreek MJ, Nielsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8(11):1450–1457. doi:10.1385/NMM:5:1:085

    Article  PubMed  CAS  Google Scholar 

  • Kuhnen CM, Chiao JY (2009) Genetic determinants of financial risk taking. PLoS ONE 4(2):e4362. doi:10.1371/journal.pone.0004362

    Article  PubMed  Google Scholar 

  • LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1(2):121–124

    PubMed  CAS  Google Scholar 

  • Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease. Mov Disord 24(12):1803–1810. doi:10.1002/mds.22678

    Article  PubMed  Google Scholar 

  • Lee JY, Jeon BS, Kim HJ, Park SS (2012) Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson’s disease. Parkinsonism Relat Disord 18(1):76–78. doi:10.1016/j.parkreldis.2011.08.009

    Article  PubMed  Google Scholar 

  • Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531

    Article  PubMed  CAS  Google Scholar 

  • Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13):4202–4210

    Article  PubMed  CAS  Google Scholar 

  • Muramatsu T, Higuchi S (1995) Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211(1):28–32. doi:10.1006/bbrc.1995.1773

    Article  PubMed  CAS  Google Scholar 

  • Ness V, Arning L, Niesert HE, Stuttgen MC, Epplen JT, Beste C (2011) Variations in the GRIN2B gene are associated with risky decision-making. Neuropharmacology 61(5–6):950–956. doi:10.1016/j.neuropharm.2011.06.023

    Article  PubMed  CAS  Google Scholar 

  • Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540–545. doi:10.1002/humu.20039

    Article  PubMed  CAS  Google Scholar 

  • Noble EP (2000) Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 15(2):79–89. doi:10.1016/S0924-9338(00)00208-X

    Article  PubMed  CAS  Google Scholar 

  • Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J (1997) Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7(5):345–348

    PubMed  CAS  Google Scholar 

  • Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Montastruc JL, Rascol O (2012) Do Parkinson’s disease patients disclose their adverse events spontaneously? Eur J Clin Pharmacol 68(5):857–865. doi:10.1007/s00228-011-1198-x

    Article  PubMed  Google Scholar 

  • Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW (1997) II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94–1. J Pharmacol Exp Ther 282(2):1020–1027

    PubMed  CAS  Google Scholar 

  • Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson’s disease. Mov Disord 25(11):1660–1669. doi:10.1002/mds.23147

    Article  PubMed  Google Scholar 

  • Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J (2003) Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 110(5):561–572. doi:10.1007/s00702-002-0805-5

    Article  PubMed  CAS  Google Scholar 

  • Rogers RD (2011) The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology 36(1):114–132. doi:10.1038/npp.2010.165

    Article  PubMed  CAS  Google Scholar 

  • Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR 4th, Benjamin J, Murphy DL, Hamer DH (1999) A genetic association for cigarette smoking behavior. Health Psychol 18(1):7–13

    Article  PubMed  CAS  Google Scholar 

  • Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1997) Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41(3):299–304. pii:S0006322396000443

    Article  PubMed  CAS  Google Scholar 

  • Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, Ono Y, Kanba S (2004) Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 29(2):134–137

    PubMed  Google Scholar 

  • Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M (2000) Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 57(7):666–673. doi:yoa9396

    Article  PubMed  CAS  Google Scholar 

  • Stoltenberg SF, Vandever JM (2010) Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk. Neuropharmacology 58(2):423–428. doi:10.1016/j.neuropharm.2009.09.010

    Article  PubMed  CAS  Google Scholar 

  • Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A (2012) Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders. Parkinsonism Relat Disord 18(4):397–399. doi:10.1016/j.parkreldis.2011.10.019

    Article  PubMed  Google Scholar 

  • Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358(6382):149–152. doi:10.1038/358149a0

    Article  PubMed  Google Scholar 

  • Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14(4):1104–1106

    Article  PubMed  CAS  Google Scholar 

  • Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997) High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74(4):439–442. doi:10.1002/(SICI)1096-8628(19970725)74:4<439:AID-AJMG16>3.0.CO;2-J

    Article  PubMed  CAS  Google Scholar 

  • Volberg RA (1994) The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 84(2):237–241

    Article  PubMed  CAS  Google Scholar 

  • Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69(6):986–996. doi:10.1002/ana.22356

    Article  PubMed  Google Scholar 

  • Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595. doi:10.1001/archneurol.2010.65

    Article  PubMed  Google Scholar 

  • Wilson D, da Silva Lobo DS, Tavares H, Gentil V, Vallada H (2012) Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci. doi:10.1007/s12031-012-9846-x

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Christophe Corvol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cormier, F., Muellner, J. & Corvol, JC. Genetics of impulse control disorders in Parkinson’s disease. J Neural Transm 120, 665–671 (2013). https://doi.org/10.1007/s00702-012-0934-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-012-0934-4

Keywords

Navigation